News

ModiQuest Research, a leading custom antibody generation and development company, will be attending the Antibody Engineering and Therapeutics conference from December 11 till December 15 in San Diego.
Immunized animals are still a key source of antibodies generated within therapeutic campaigns to obtain high affinity antibody drug candidates. Therefore, humanization and de-risking of these antibodies is an important antibody engineering step in the development of therapeutic antibodies. However, humanization is still characterized by a high risk as affinity and specificity can be lost during the humanization process.
ModiQuest Research will present a full antibody engineering platform (ModiTuneTM) to obtain humanized antibodies with similar affinity and specificity as the original antibody.
Meet Jos Raats (CEO) and Nienke Smits (Business development) at booth #321 or at our poster to discover our state of the art antibody generation and engineering platforms and to discuss your specific antibody projects.
If you have any questions, inquiries or if you would like to arrange a meeting during the event, please don’t hesitate to contact us. Mail to: nsmits@modiquestresearch.com or call us on +31 412 846 000 to fix a time to talk.
Hope to meet you at the Antibody Engineering and Therapeutics conference in San Diego!

Jos Raats and Nienke Smits

Nienke Smits (nsmits@modiquestresearch.com)

 

Place your order for antibody MQR2.1201, MQR2.1301, MQR2.1401, MQR2.1501 and/or MQR2.1601 get a 30% introduction discount on these products (only in November and December 2017)!*
ModiQuest Research BV today announced that it has expanded its antibody portfolio with five different  monoclonal human antibodies. These antibodies are highly specific and developed for the detection of the following targets:
MQR2.1201-100 against Bromodomain-containing protein 4 (BRD4). More information about pricing and delivery times, as well as a product sheet can be found on: MQR2.1201
MQR2.1301-100 against WD repeat-containing protein 5 (WDR5). More information about pricing and delivery times, as well as a product sheet can be found on: MQR2.1301
MQR2.1401-100 against Bromodomain and PHD finger-containing protein 3. More information about pricing and delivery times, as well as a product sheet can be found on: MQR2.1401
MQR2.1501-100 against Bromodomain-containing protein 1. More information about pricing and delivery times, as well as a product sheet can be found on: MQR2.1501
MQR2.1601-100 against protein arginine N-methyltransferase 3 (PRMT3). More information about pricing and delivery times, as well as a product sheet can be found on: MQR2.1601
To activate the 30% introduction discount please use promotion code 20171130 on your purchase order.
Please visit our website, www.modiquestresearch.com, to look at our catalogue products or you can place your order directly via sales@modiquestresearch.com
* cannot be combined with any other offer


Citryll – ModiQuest will present at 2017 ACR/ARHP Annual Meeting, in San Diego, November 03-08, 2017

A poster will be presented entitled “Expanded Therapeutic ACPA Utility for Different NET-Driven Human (Autoimmune) Diseases”.

Abstract is available online at: http://acrabstracts.org/abstract/expanded-therapeutic-acpa-utility-for-different-net-driven-human-autoimmune-diseases/

Details of the session see below:

  • Session Name: Innate Immunity and Rheumatic Disease Poster I
  • Date and Session Time: Sunday, November 5, 2017: 9:00 AM-11:00 AM

 

ModiQuest Research, a leading custom antibody generation and development company, will be attending the Protein engineering summit from October 31 till November 2 in Boston.
Immunized animals are still a key source of antibodies generated within therapeutic campaigns to obtain high affinity antibody drug candidates. Therefore, humanization and de-risking of these antibodies is an important antibody engineering step in the development of therapeutic antibodies. However, humanization is still characterized by a high risk as affinity and specificity can be lost during the humanization process.
ModiQuest Research will present a full antibody engineering platform (ModiTuneTM) to obtain humanized antibodies with similar affinity and specificity as the original antibody.
Meet Jos Raats (CEO) and Nienke Smits (Business development) at booth #55 or at our poster to discover our state of the art antibody generation and engineering platforms and to discuss your specific antibody projects.
If you have any questions, inquiries or if you would like to arrange a meeting during the event, please don’t hesitate to contact us. Mail to: nsmits@modiquestresearch.com or call us on +31 412 846 000 to fix a time to talk.
Hope to meet you at the European Antibody Congress in Basel!

Jos Raats and Nienke Smits

Nienke Smits (nsmits@modiquestresearch.com)

 

ModiQuest Research, a leading custom antibody generation and development company, will be attending the Protein engineering summit this May 1-5 in Boston.
Immunized animals are still a key source of antibodies generated within therapeutic campaigns to obtain high affinity antibody drug candidates. Therefore, humanization and de-risking of these antibodies is an important antibody engineering step in the development of therapeutic antibodies. However, humanization is still characterized by a high risk as affinity and specificity can be lost during the humanization process.
ModiQuest Research will present a full antibody engineering platform (ModiTuneTM) to obtain humanized antibodies with similar affinity and specificity as the original antibody.
Meet Debby Kruijsen (Head contract research) and Nienke Smits (Business development) at booth #209 or at our poster to discover our state of the art antibody generation and engineering platforms and to discuss your specific antibody projects.
If you have any questions, inquiries or if you would like to arrange a meeting during the event, please don’t hesitate to contact us. Mail to: nsmits@modiquestresearch.com or call us on +31 412 846 000 to fix a time to talk.
Hope to meet you at the PEGS Boston!

Debby Kruijsen and Nienke Smits

Dr. D. Kruijsen (dkruijsen@modiquestresearch.com)

shopping basket 0 items

Shopping Cart

0

Your shopping cart is empty:

please visit the shop